- Home
- Publications
- Publication Search
- Publication Details
Title
Chemokine receptor expression by inflammatory T cells in EAE
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-07-04
DOI
10.3389/fncel.2014.00187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
- (2014) T. Yamazaki et al. JOURNAL OF IMMUNOLOGY
- Phenotype Switching by Inflammation-Inducing Polarized Th17 Cells, but Not by Th1 Cells
- (2014) G. Shi et al. JOURNAL OF IMMUNOLOGY
- Interactions between Neutrophils, Th17 Cells, and Chemokines during the Initiation of Experimental Model of Multiple Sclerosis
- (2014) Dagmara Weronika Wojkowska et al. MEDIATORS OF INFLAMMATION
- MOG extracellular domain (p1–125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE
- (2014) Jyothi T Mony et al. Multiple Sclerosis Journal
- Th1-mediated experimental autoimmune encephalomyelitis is CXCR3 independent
- (2013) Stephen J. Lalor et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2013) R. Naves et al. JOURNAL OF IMMUNOLOGY
- The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis
- (2013) Kota Moriguchi et al. JOURNAL OF NEUROIMMUNOLOGY
- CC Chemokine Ligand 20 and Its Cognate Receptor CCR6 in Mucosal T Cell Immunology and Inflammatory Bowel Disease: Odd Couple or Axis of Evil?
- (2013) Adrian Y. S. Lee et al. Frontiers in Immunology
- Regulation of CCL20 expression in astrocytes by IL-6 and IL-17
- (2012) Gordon P. Meares et al. GLIA
- IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability
- (2012) Claudia Hindinger et al. PLoS One
- Capture, crawl, cross: the T cell code to breach the blood–brain barriers
- (2012) Britta Engelhardt et al. TRENDS IN IMMUNOLOGY
- Pathogenic CD8 T Cells in Multiple Sclerosis and Its Experimental Models
- (2012) Eric S. Huseby et al. Frontiers in Immunology
- Interferon-γ Orchestrates the Number and Function of Th17 Cells in Experimental Autoimmune Encephalomyelitis
- (2011) Nele Berghmans et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- The blood–brain barrier, chemokines and multiple sclerosis
- (2010) David W. Holman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis
- (2010) Áine C. Murphy et al. BRAIN BEHAVIOR AND IMMUNITY
- CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease
- (2010) Romeo Sporici et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- EAE mediated by a non-IFN-γ/non-IL-17 pathway
- (2010) Mark A. Kroenke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease
- (2010) Henrik Toft-Hansen et al. GLIA
- Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune Encephalomyelitis
- (2010) Zizhen Kang et al. IMMUNITY
- Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
- (2010) M. Mehling et al. NEUROLOGY
- Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum
- (2010) M. Müller et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
- (2010) Helena S. Domingues et al. PLoS One
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- CCR6 regulates EAE pathogenesis by controlling regulatory CD4+T‐cell recruitment to target tissues
- (2009) Ricardo Villares et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Late Developmental Plasticity in the T Helper 17 Lineage
- (2009) Yun Kyung Lee et al. IMMUNITY
- Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice
- (2009) David Bending et al. JOURNAL OF CLINICAL INVESTIGATION
- Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
- (2009) A. Jager et al. JOURNAL OF IMMUNOLOGY
- Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response
- (2009) A. Liston et al. JOURNAL OF IMMUNOLOGY
- Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis
- (2009) Adam Elhofy et al. JOURNAL OF NEUROIMMUNOLOGY
- The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut
- (2009) C Wang et al. Mucosal Immunology
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
- (2009) Andrea Reboldi et al. NATURE IMMUNOLOGY
- Gaining entry to an uninflamed brain
- (2009) Robert C Axtell et al. NATURE IMMUNOLOGY
- Nuanced roles of cytokines in three major human brain disorders
- (2008) Lawrence Steinman JOURNAL OF CLINICAL INVESTIGATION
- Tracing Functional Antigen-Specific CCR6+ Th17 Cells after Vaccination
- (2008) Johann Pötzl et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now